Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Pletsch-Borba, Laura [VerfasserIn]   i
 Turzanski Fortner, Renée [VerfasserIn]   i
 Katzke, Verena [VerfasserIn]   i
 Johnson, Theron S. [VerfasserIn]   i
 Groß-Weissmann, Marie-Luise [VerfasserIn]   i
 Hoffmeister, Michael [VerfasserIn]   i
 Bugert, Peter [VerfasserIn]   i
 Kaaks, Rudolf [VerfasserIn]   i
 Kühn, Tilman [VerfasserIn]   i
Titel:Biomarkers of vascular injury and type 2 Diabetes
Titelzusatz:a prospective study, systematic review and meta-analysis
Verf.angabe:Laura Pletsch-Borba, Cora Watzinger, Renée Turzanski Fortner, Verena Katzke, Lukas Schwingshackl, Solomon A. Sowah, Anika Hüsing, Theron Johnson, Marie-Luise Groß, Sandra González Maldonado, Michael Hoffmeister, Peter Bugert, Rudolf Kaaks, Mirja Grafetstätter and Tilman Kühn
E-Jahr:2019
Jahr:27 November 2019
Umfang:19 S.
Fussnoten:Gesehen am 19.02.2020
Titel Quelle:Enthalten in: Journal of Clinical Medicine
Ort Quelle:Basel : MDPI, 2012
Jahr Quelle:2019
Band/Heft Quelle:8(2019,12) Artikel-Nummer 2075, 19 Seiten
ISSN Quelle:2077-0383
Abstract:Data on biomarkers of vascular injury and type 2 diabetes (T2D) risk from prospective studies are lacking. We evaluated seven biomarkers of vascular injury in relation to T2D. Additionally, a meta-analysis was performed. From the EPIC–Heidelberg cohort, 2224 participants were followed-up from baseline for 16 (median) years. E-Selectin, P-Selectin, intercellular adhesion molecule 3 (ICAM3), thrombomodulin, thrombopoietin, glycoprotein IIb/IIIa and fibrinogen levels were measured in baseline blood samples. The systematic review and meta-analysis included prospective studies identified through MEDLINE and Web of Science that investigated the association between mentioned biomarkers and T2D. The study population included 55% women, median age was 50 years, and 163 developed T2D. ICAM3 was associated with lower T2D risk (fully adjusted HRhighest vs. lowest tertile 0.62 (95% CI: 0.43, 0.91)), but no other studies on ICAM3 were identified. Overall, fifteen studies were included in the systematic review and meta-analysis (6,171 cases). E-Selectin was associated with higher T2D risk HRper SD: 1.34 (95% CI: 1.16, 1.54; I2 = 63%, n = 9 studies), while thrombomodulin was associated with lower risk HRper SD: 0.82 (95% CI: 0.71, 0.95; I2 = 0%, n = 2 studies). In the EPIC–Heidelberg, ICAM3 was associated with lower T2D risk. The meta-analysis showed a consistent positive association between E-Selectin and T2D. It was also suggestive of an inverse association between thrombomodulin and T2D, although further studies are needed to corroborate this finding.
DOI:doi:10.3390/jcm8122075
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.3390/jcm8122075
 Verlag: https://www.mdpi.com/2077-0383/8/12/2075
 DOI: https://doi.org/10.3390/jcm8122075
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:E-Selectin
 Epidemiology
 ICAM3
 P-Selectin
 thrombomodulin
 Type 2 Diabetes
 vascular injury biomarkers
K10plus-PPN:1690348747
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68491081   QR-Code
zum Seitenanfang